Successive deliveries of reagents for determining the presence of DNA of 14 HR-HPV types, along with the lease of molecular analyzers as a system compatible with the existing LBC system for the Maria Skłodowska-Curie National Institute of Oncology - State Research Institute, Gliwice Branch

The Maria Skłodowska-Curie National Institute of Oncology - National Research Institute, Gliwice Branch in Poland from Europe region had released this tender for 1. The Ordering Party does not allow partial bids. The subject of this contract includes the lease of a system for identifying the presence of DNA for 14 HR-HPV types, along with the supply of dedicated reagents for performing the aforementioned tests, compatible with the Ordering Party's SlidePrep liquid-based cytology system. The Ordering Party intends to complete the contract as a single task. The Ordering Party aims to consolidate all necessary tests on the smallest possible number of systems (1 SlidPrep + 2 molecular analyzers from a single company), so that the largest number of laboratory test results can be issued in the shortest time possible and at the best possible price and quality (a company with certified reagents and validated equipment, and diagnostics for the largest number of HR-HPV subtypes on the market). Offering different systems significantly increases the cost of maintaining them and the cost of performing tests (purchasing other, new devices). The lack of division into tasks does not threaten to restrict competition, including limiting the participation of small and medium-sized enterprises (SMEs) in the public procurement market. 2. The description of the subject of the contract and the terms of contract performance are contained in the appendices: 2.1. Price specification – Appendix No. 2 to the Specifications of Terms of Reference 2.2. Draft contract provisions that will be introduced into the contract – Appendix No. 4 to the Specifications of Terms of Reference 3. The Ordering Party allows the possibility of submitting equivalent offers – the description of equivalence is included in Chapter IV of the Specifications of Terms of Reference. 4. The Ordering Party does not envisage an electronic auction or supplementary orders. 5. Information on Contractors jointly applying for the contract is included in Chapter IX of the Specifications of Terms of Reference. 6. The Ordering Party envisages the possibility of changes to the provisions of the concluded contract (so-called contractual changes based on art. 455 sec. 1 item 1 of the Act) in relation to the content of the offer based on which the Contractor was selected, in accordance with the conditions contained in Appendix No. 4 to the Specifications of Terms of Reference. An amendment to the contract may also take place in the cases referred to in art. 455 sec. 1 items 2-4 and sec. 2 of the Public Procurement Act. 7. The information clause resulting from the content of art. 13 of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC, the Contracting Authority has included in the tender specifications. 8. The tender validity period is: 90 days. The tender validity period begins on the deadline for submission of tenders. This date is the first day of the tender validity period. This means that the tender validity period expires on 11 January 2027. 11. Detailed information regarding this procedure is included in the tender specifications. with tender notice no. 683454-2026 published on 07 Oct 2026. The tender expired on 14 Oct 2026. This tender is sourced from TED Europa and is eligible for suppliers interested in Chemical reagents. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 15304586.